Welcome! Login | Register
 

Worcester Man Arrested for Trafficking & Sexually Assaulting 14-Year-Old Girl—Worcester Man Arrested for Trafficking & Sexually Assaulting…

Rhodes Announces Candidacy for Milford Board of Selectmen—Rhodes Announces Candidacy for Milford Board of Selectmen

Horowitz: President Obama - A Consequential and Successful Presidency—Horowitz: President Obama - A Consequential and Successful…

Organize + Energize: How Much do You Need to be Happy?—Organize + Energize: How Much do You Need…

Steelers’ Tomlin Calls Patriots “A-Holes” in Facebook Live Video—Steelers' Tomlin Calls Patriots "A-Holes" in Facebook Live…

10 Great Pets in Need of Loving Homes - January 17, 2017—10 Great Pets in Need of Loving Homes…

Man Arrested for Stabbing Sister-in-Law and Another Man in Worcester—Man Arrested for Stabbing Sister-in-Law, Another Man in…

College Admissions: Best Ski + Snowboard Colleges in the East—Ready to hit the slopes?

Smart Benefits: The Importance of Updated Labor Law Posters—Smart Benefits: The Importance of Updated Labor Law…

Patriots to Host Steelers in AFC Championship Game—Patriots to Host Steelers in AFC Championship Game

 
 

AG Announces $68.5 Million Settlement with AstraZeneca

Friday, March 11, 2011

 

Attorney General Peter Kilmartin announced today that a $68.5 million dollar settlement has been reached with AstraZeneca Pharmaceuticals.

This settlement, which is the largest ever multi-state consumer protection-based pharmaceutical settlement, is expected to bring $908,838 to the state.

The settlement stems from a complaint alleging that AstraZeneca used deceptive practices to market the antipsychotic drug Seroquel for off-label uses, according to the Attorney General. The company was accused of withholding information on the drug’s dangerous potential side effects, in addition to the negative results of scientific study done that tested the safety of the drug.

“This settlement shows the commitment of this office to protect consumers from deceptive marketing and advertising practices by big pharmaceutical companies,” Kilmartin said.

Company promises changes

AstraZeneca has promised to alter the way that it markets Seroquel, eliminating the misleading practices in question. Along with the $68.5 million payment, under the settlement AstraZeneca must comply with provisions addressing numerous concerns that an extensive 3-year investigation yielded. For example, AstraZeneca must have policies in place to ensure that sales personnel do not promote to health care providers who are unlikely to prescribe Seroquel for an FDA-approved use.

Other states participating in the investigation and settlement were: Florida, Illinois, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Washington, West Virginia and Wisconsin.
 

 

Enjoy this post? Share it with others.

 

X

Stay Connected — Free
Daily Email